Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

KURA · ISSUER CIK 1422143

Kura Oncology, Inc.

Between Aug 1, 2026 and Oct 29, 2026, 7 Kura Oncology, Inc. insiders reported $2.4M of open-market purchases and $1.7M of sales on SEC Form 4. The largest buyer was Wilson Troy Edward (President and CEO, Director), with $2.4M.

SEC insider filings
↗7 insiders filed

Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 6 of 8 sales were reported under a 10b5-1 plan.

$2.4MInsider buying
$1.7MInsider selling
+$643KNet open-market
Sep 29, 2026Latest filing
Form 4 trades at Kura Oncology, Inc.
TickerInsiderTypeOwned
Sep 29, 202618:30Sep 28, 2026KURAChief Legal OfficerS · Sell10b5-1$10.50−8,442187,002-4%−$89K
Sep 29, 202618:30Sep 29, 2026from Sep 28, 2026KURAChief Operating OfficerS · Sell10b5-1$10.59−10,574142,986-7%−$112K
Sep 29, 202618:30Sep 29, 2026from Sep 28, 2026KURAChief Medical OfficerS · Sell10b5-1$10.67−41,250141,095-23%−$440K
Sep 29, 202618:30Sep 28, 2026KURASVP, Finance & AccountingS · Sell$10.50−4,607142,428-3%−$48K
Sep 29, 202618:30Sep 29, 2026from Sep 28, 2026KURAChief Commercial OfficerS · Sell10b5-1$10.63−32,450136,819-19%−$345K
Sep 25, 202616:05Sep 24, 2026KURAChief Scientific OfficerS · Sell$10.83−20,72642,327-33%−$225K
Sep 25, 202616:05Sep 24, 2026KURAChief Scientific OfficerM · Exercise$6.15+30,00063,053+91%$185K
Aug 24, 202617:30Aug 24, 2026KURAPresident and CEO, DirectorP · Buy$12.39+100,000479,194+26%+$1.2M-1.1%-14.8%
Aug 24, 202617:30Aug 21, 2026KURAChief Commercial OfficerS · Sell10b5-1$11.89−4,345169,269-3%−$52K
Aug 21, 202616:30Aug 19, 2026KURAChief Legal OfficerS · Sell10b5-1$12.63−31,487195,444-14%−$398K
Aug 17, 202616:45Aug 17, 2026KURAPresident and CEO, DirectorP · Buy$11.12+100,000379,194+36%+$1.1M-8.3%-5.0%
Kura Oncology, Inc. (KURA) Insider Trading | Shameless Cloning